Literature DB >> 23279620

Incidence of residual nonmelanoma skin cancer in excisions after shave biopsy.

Kurt Grelck1, Sean Sukal, Les Rosen, Gabriel P Suciu.   

Abstract

BACKGROUND: Nonmelanoma skin cancer is an increasingly common disease that is typically treated surgically. After histopathologic confirmation by biopsy, the carcinoma is typically removed by excision, but not all excisional specimens contain residual carcinoma.
OBJECTIVES: To define the rate of residual basal and squamous cell carcinomas within excisional specimens after shave biopsy in a general dermatology office.
METHODS: We retrospectively reviewed 439 consecutive cases sent to a single dermatopathology lab from a practitioner's general dermatology office who also performs Mohs micrographic surgery. One hundred cases had a histopathologically proven carcinoma on biopsy with subsequent excision. Histopathologic type, location, age, sex, and time from biopsy to excision were all analyzed for statistical association.
RESULTS: Of 57 cases of basal cell carcinoma, 34 (59.6%) had positive residuals. Of 43 cases of squamous cell carcinoma, 12 (27.9%) had positive residuals. Histologic type was significantly associated (p = .002) with residual carcinoma in excisional specimens, with basal cells 2.13 times as likely to have residual carcinoma present.
CONCLUSION: The rate of residual nonmelanoma carcinoma in excision specimens after shave biopsy was found to be different from previously reported in the literature. These data may have therapeutic ramifications if further substantiated.
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23279620     DOI: 10.1111/dsu.12056

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  5 in total

1.  A Protease-Activated Fluorescent Probe Allows Rapid Visualization of Keratinocyte Carcinoma during Excision.

Authors:  Ethan Walker; Yiqiao Liu; InYoung Kim; David L Wilson; James P Basilion; Daniel L Popkin; Mark Biro; Sukanya Raj Iyer; Harib Ezaldein; Jeffrey Scott; Miesha Merati; Rachel Mistur; Bo Zhou; Brian Straight; Joshua J Yim; Matthew Bogyo; Margaret Mann
Journal:  Cancer Res       Date:  2020-03-04       Impact factor: 12.701

2.  Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience.

Authors:  Eileen S Flores; Miguel Cordova; Kivanc Kose; William Phillips; Anthony Rossi; Kishwer Nehal; Milind Rajadhyaksha
Journal:  J Biomed Opt       Date:  2015-06       Impact factor: 3.170

3.  Multispectral autofluorescence dermoscope for skin lesion assessment.

Authors:  Renan Arnon Romano; Ramon Gabriel Teixeira Rosa; Ana Gabriela Salvio; Javier A Jo; Cristina Kurachi
Journal:  Photodiagnosis Photodyn Ther       Date:  2020-03-02       Impact factor: 3.631

4.  Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions.

Authors:  John Hornberger; Daniel M Siegel
Journal:  JAMA Dermatol       Date:  2018-09-01       Impact factor: 10.282

Review 5.  Updates on the Management of Non-Melanoma Skin Cancer (NMSC).

Authors:  Artur Fahradyan; Anna C Howell; Erik M Wolfswinkel; Michaela Tsuha; Parthiv Sheth; Alex K Wong
Journal:  Healthcare (Basel)       Date:  2017-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.